Glaxosmithkline | Créances Commerciales



Trade Debtors Changement Date
AbbVie USD 12.48B 1.56B 2025-03
Amgen USD 8.7B 569M 2025-06
AstraZeneca USD 16.24B 1.42B 2025-06
Aurora Cannabis CAD 49.52M 9.36M 2024-12
Bausch Health Companies USD 2.21B 138M 2025-06
Bristol-Myers Squibb USD 15.1B 515M 2025-06
Canopy Growth CAD 49.06M 7.2M 2024-12
Corcept Therapeutics USD 64.57M 2.75M 2025-06
Drreddys Laboratories INR 111.49B 8.65B 2024-12
Eli Lilly USD 17.21B 3.2B 2025-06
GlaxoSmithKline GBP 7.7B 196M 2025-06
Glaxosmithkline GBP 7.32B 542M 2024-12
J&J USD 16.02B 1.18B 2025-03
Merck USD 12.72B 1.14B 2025-06
Novartis USD 9.18B 451M 2025-06
Pacira USD 114.37M 9.62M 2025-06
Perrigo USD 678.2M 38.6M 2025-06
Pfizer USD 16.09B 1.35B 2025-06
Prestige Brands USD 168.4M 25.89M 2025-06
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 8.21B 7.76B 2025-06
Supernus Pharmaceuticals USD 140.83M 4.81M 2025-06
Takeda JPY 679.53B 45.72B 2025-06
Teva Pharmaceutical Industries USD 3.56B 180M 2025-06
Zoetis USD 1.54B 179M 2025-06


Glaxosmithkline Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.